A critical appraisal of statistical pitfalls and clinical relevance of meta-analysis involving hepatitis C virus and sofosbuvir
Letter to the Editor
- 232 Downloads
KeywordsCritical Thinking Comparable Intervention Indirect Comparison Included Trial Sofosbuvir
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Conflicts of interest
The author does not have any conflicts of interest.
- 1.Yang HJ, Ryoo JY, Yoo BK. Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection. Int J Clin Pharm. 2015. doi: 10.1007/s11096-015-0144-x.
- 4.Clinicaltrials.gov (numbers: NCT01641640, NCT01497366, NCT01542788, NCT01604850, NCT01682720, NCT01701401, NCT01768286, NCT01851330). https://clinicaltrials.gov/. Accessed 24 Jul 2015.
- 5.Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. Cochrane Collab. 2011. http://www.cochrane-handbook.org. Accessed 24 Jul 2015.
© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015